Program for all days

Better Kidney Health

The Interconnected Kidney

Preserving Kidney Health

The Smart Kidney

Plenary Sessions

WCN Courses

Spotlight Sessions

Special Sessions

Global Kidney Policy Forum

Welcome Event

Topical Networking

Poster Sessions

28 March 2026

Time	Session

8:30 a.m. 10 a.m.	Renal Pathology Course: Transplantation Related Kidney Diseases AhmedKalebi Moderator Kenya PeterBoor Moderator Germany SuryaSeshan Moderator United States Update on Banff Transplant Pathology Classification AgnesFogo Speaker United States Kidney Lesions Following Stem Cell Transplantation SuryaSeshan Speaker United States Digital Pathology and Artificial Intelligence Applications in Kidney Transplant Pathology PeterBoor Speaker Germany Q&A Session 301 - 302																		Tools to Strengthen Global Kidney Trials: Design, Innovative Endpoints, and Communication Across Regions 1 Breaking New Ground in Clinical Trials Andrea Viecelli Moderator Switzerland BrendanSmyth Moderator Australia DavidWheeler Moderator United Kingdom High Level Summary of the Two Previous Webinars AdeeraLevin Speaker Canada Designing Trials for Inclusivity and Generalizability Andrea Viecelli Speaker Switzerland Trials Without Borders RathikaKrishnasamy Speaker Australia Use of Novel Tools in Kidney Research Pedro HenriqueFranca Gois Speaker Australia Q&A Session 303																		Onco-Nephrology Course: Acute Kidney Injury (AKI) in the Cancer Patient KenarJhaveri Moderator United States Maria JoseSoler Moderator Spain SabineKaram Moderator United States AKI Due to Chemotherapy Diana CarolinaVargas Angel Speaker Colombia AKI Due to Targeted Therapy MotokoYanagita Speaker Japan AKI Due to Immunotherapy Maria JoseSoler Speaker Spain Roundtable Discussion KenarJhaveri Moderator United States 304																		Conservative Kidney Management: What Are Kidney Supportive Care (KSC) and Conservative Kidney Management (CKM)? SaraDavison Moderator Canada Yoshiyuki Kizawa Moderator Introduction to concepts/principles of Kidney Supportive Care and Conservative Kidney Management SaraDavison Speaker Canada Joint Talk: Planning for conservative kidney management - A Tale of Two Cities BarnabyHole Speaker United Kingdom PeaceBagasha Speaker Uganda Essential Communication Skills for Successful Advance Care Planning BarnabyHole Speaker United Kingdom Q&A Session 311 - 312																		Local Kidney Registries in Action: Regional Insights and Innovations Kidney Registries in Action: global collaboration to improve access to treatment and patient outcomes GeorginaIrish Moderator Australia JunichiHoshino Moderator Japan Welcome FergusCaskey Speaker United Kingdom Introduction ToshihideNaganuma Speaker Japan Lessons From Developing a National Hemodialysis Registry in Nepal DibyaSingh Shah Speaker Nepal Status of Dialysis Therapy in Mongolia: Insights From the National Dialysis Registry AdiyaSaruultuvshin Speaker Mongolia Applying National Kidney Registry Data to Japanese Clinical Practice Guidelines JunichiHoshino Speaker Japan Panel Discussion 313 - 314																		Annual Review of Nephrology Course 1 KenjiMatsui Moderator United States MitchellRosner Moderator United States Update on Diabetes Kidney Disease Management SunitaBavanandan Speaker Malaysia New Drugs for Polycystic Kidney Disease MichelChonchol Speaker United States B Cell Targeted Therapies for Glomerular Diseases RichardLafayette Speaker United States Q&A Session 501 - 502																		Interventional Nephrology Course: Dialysis Access in Action: Mapping, Cannulation, and Volume Assessment BernardoMoguel González Moderator Mexico MayuriTrivedi Moderator mayuritrivedi80@gmail.comIndia ToshihideNaganuma Moderator Japan VandanaNiyyar Moderator United States Tunneled Central Venous Catheter Placement and Troubleshooting: Simulation-based Training BernardoMoguel González Speaker Mexico Hoon SukPark Speaker South Korea Hemodialysis Access: Venous Mapping, AVF Assessment, Ultrasound Maturity Evaluation, and Simulation-guided Cannulation ToshihideNaganuma Speaker Japan VandanaNiyyar Speaker United States Volume Assessment Using Lung Ultrasound and Inferior Vena Cava Imaging BhavnaBhasin-Chhabra Speaker United States EduardoRios Argaiz Speaker Mexico Q&A Session 503
10:30 a.m. 12 p.m.	Renal Pathology: Native Kidney Disease Pathology – Advances/Update Mineaki Kitamura Moderator Japan PeterBoor Moderator Germany Spectrum of IgG4 Related Kidney Diseases TakakoSaeki Speaker Japan Spectrum of Tropical Infections and Renal Lesions in Parasitic Diseases AhmedKalebi Speaker Kenya From Uncertainty to Diagnosis: Genomics in Undetermined Kidney Disease LaurentMesnard Speaker France Q&A Session 301 - 302																		Tools to Strengthen Global Kidney Trials: Design, Innovative Endpoints, and Communication Across Regions 2 Global Trials Perspectives KatherineTuttle Moderator United States MegumiOshima Moderator Japan VivekKumar Moderator India Japanese Perspective MegumiOshima Speaker Japan African Perspective RobertKalyesubula Speaker Uganda Insights on Consent Challenges in Low and Middle-income Countries ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States Closing the Loop: Returning Results to Participants: Why and How AdeeraLevin Speaker Canada BillWang Speaker Hong Kong, China Q&A Session 303																		Onco-Nephrology Course: Electrolyte Disturbances in the Cancer Patient KenarJhaveri Moderator United States Maria JoseSoler Moderator Spain SabineKaram Moderator United States Hyponatremia in Patients with Cancer SanjeevNair Speaker India Hypercalcemia in Patients with Cancer MohamedHassanein Speaker Egypt Hypomagnesemia and Hypophosphatemia in Patients With Cancer JolantaMalyszko Speaker Poland Roundtable Discussion KenarJhaveri Moderator United States 304																		Conservative Kidney Management: How to deliver CKM - A Focus on Symptom Management SaraDavison Moderator Canada PeaceBagasha Moderator Uganda Managing Restless Legs, CKD-Associated Pruritus, and Insomnia in Conservative Kidney Management BrendanSmyth Speaker Australia Management of Pain in Conservative Kidney Management PramoteEuasobhon Speaker Thailand Management of Fatigue and Mental Health in Conservative Kidney Management PeaceBagasha Speaker Uganda Q&A Session 311 - 312																		Real-World Data and Registries in Clinical Research AlejandroFerreiro-Fuentes Moderator Uruguay FergusCaskey Moderator United Kingdom Introduction GeorginaIrish Speaker Australia Embedding Randomization in a National CKD Registry: The SACK Apixaban Study MarieEvans Speaker Sweden Platform Trials Using Routine Data for Pediatric Rare Diseases DorotheaNitsch Speaker United Kingdom Lessons Learned From Hemodialysis and Peritoneal Dialysis Trials: ANZDATA Insights StephenMcdonald Speaker Australia Q&A 313 - 314																		Annual Review of Nephrology Course 2 SolaAoun Bahous Moderator Lebanon Yoshihito Nihei Moderator Japan Linking Renal Pathology to Kidney Function Jonathan Barratt Speaker United Kingdom Management of C3 Glomerulopathy: From Diagnosis to Targeted Therapy SHOICHIMARUYAMA Speaker Japan Update on the Cardio-Kidney Metabolic Syndrome SolaAoun Bahous Speaker Lebanon Q&A Session 501 - 502																		Interventional Nephrology Course: Ultrasound in Nephrology- From Diagnosis to Intervention BernardoMoguel González Moderator Mexico MayuriTrivedi Moderator mayuritrivedi80@gmail.comIndia ToshihideNaganuma Moderator Japan VandanaNiyyar Moderator United States Diagnostic Ultrasound of the Kidneys and Bladder ToshihideNaganuma Speaker Japan VandanaNiyyar Speaker United States Kidney Biopsy BernardoMoguel González Speaker Mexico Hoon SukPark Speaker South Korea Volume Assessment Using Cardiac Ultrasound and the VExUS Score BhavnaBhasin-Chhabra Speaker United States EduardoRios Argaiz Speaker Mexico Q&A Session 503
11 a.m. 11:15 a.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Opening Remarks A Turning Point for Kidney Health: Leveraging the WHO Resolution for Regional and National Impact Speaker: Marcello Tonelli, ISN President The GKPF and the 10 Global Kidney Health Recommendations Speaker: Ifeoma Ulasi, ISN AWG Chair 315
11:15 a.m. 12:05 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Japan’s CKD Strategy in Action — Lessons From an Aging Society Moderator: Ifeoma Ulasi, ISN AWG Chair Addressing Kidney Disease in Japan: How Does the National Policy Meet Global Commitments Speaker: Yosuke Yamada, Deputy Director Cancer and Disease Control Division Public Health Bureau the Ministry of Health, Labour, and Welfare Transforming Kidney Care Through National Strategy: A Nephrologist Perspective Speaker: Naoki Kashihara, Chair Professor and Vice President, Kawasaki Medical School, Department of Nephrology and Hypertension Living the Strategy: A Patient’s Perspective on Navigating Kidney Care in Japan Speaker: Takeshi Shukunobe, CEO, PPeCC,Inc. Financing Kidney Health: Sustainable and Innovative National Approaches Speaker: Yusuke Suzuki, Professor, Department of Nephrology, Juntendo University Faculty of Medicine Q&A Moderator: Ifeoma Ulasi, ISN AWG Chair 315
12:05 p.m. 1:05 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Advancing Kidney Health Across North and East Asia: Regional Challenges and Opportunities Moderator: Iqbal Hafidz, ISN AWG Deputy Chair Integrating Kidney Health into NCD Strategies: A Regional Perspective from WHO Speaker: Huong Tran, Director of Health Promotion, Disease Prevention and Control at WHO Regional Office for the Western Pacific Data-driven Kidney Health: The Taiwan Experience Speaker: Wu Mai Szu, President, Taipei Medical University Advancing Kidney Disease Prevention and Care in China Speaker: Luxia Zhang, Deputy Dean, National Institute of Health Data Science, Peking University Addressing Kidney Disease through the National Health Plan 2030 (HP2030) Speaker: Kook-Hwan Oh, Division of Nephrology, Department of Internal Medicine, Seoul University Bridging the Gap Between Policy and Patient Reality Speaker: Manvir Victor, ISN PLAG Chair Q&A Moderator: Iqbal Hafidz, ISN AWG Deputy Chair 315
12:15 p.m. 1:15 p.m.	Renal Pathology Course: Clinical-Pathologic Correlation Case Presentations AhmedKalebi Moderator Kenya SuryaSeshan Moderator United States Case Discussion 1 AgnesFogo Speaker United States Case Discussion 2 SuchinWorawichawong Speaker Thailand Case Discussion 3 Mineaki Kitamura Speaker Japan Q&A 301 - 302																		Tools to Strengthen Global Kidney Trials: Design, Innovative Endpoints, and Communication Across Regions 3 Implementation Science in Action MichaelWalsh Moderator Canada MegJardine Moderator Australia Practical Aspects of Implementation Science; Hands-on Studies Tae WonYi Speaker Canada Value of Implementation Science RukshanaShroff Speaker United Kingdom Implementation Science in Digital Health: Clinical Trials Using Mobile Applications for Patient Interventions YusukeSakaguchi Speaker Japan Take Home Messages MegJardine Speaker Australia 303																		Onco-Nephrology Course: Onco-Nephrology in Special Populations KenarJhaveri Moderator United States Maria JoseSoler Moderator Spain SabineKaram Moderator United States Onco-nephrology in the Kidney Transplant Population RobertCarroll Speaker robert.carroll@health.sa.gov.auAustralia Onco-Hypertension: Mechanisms, Monitoring, and Management SabineKaram Speaker United States GFR Estimation in Patients With Cancer ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States Q&A and Final Remarks KenarJhaveri Moderator United States 304																		Conservative Kidney Management: How to deliver CKM - Why It Is Everybody's Business SaraDavison Moderator Canada PeaceBagasha Moderator Uganda Managing Metabolic Complications of Kidney Failure in Conservative Kidney Management SaraDavison Speaker Canada End-of-Life Care in Conservative Kidney Management: Symptom-focused Approaches NandiniVallath Speaker India Q&A Session 311 - 312																		From Definition to Data: Advancing Standardisation in CKD Registries MarieEvans Moderator Sweden StephenMcdonald Moderator Australia Why We Need Standardised Data in CKD Registries AlejandroFerreiro-Fuentes Speaker Uruguay UK Experience in Harmonizing Routine CKD Data for Research SamiraBell Speaker United Kingdom Overcoming Barriers to Global CKD Data Standardization JamesWetmore Speaker United States Q&A 313 - 314																		Annual Review of Nephrology Course 3 BiancaDavidson Moderator South Africa Lori-AnnFisher Moderator Jamaica SHOICHIMARUYAMA Moderator Japan How Do I Manage Hepatorenal Syndrome? Lori-AnnFisher Speaker Jamaica How Do I Manage: Checkpoint Inhibitor-associated AKI MitchellRosner Speaker United States Q&A Session 501 - 502																		Interventional Nephrology Course: PD Catheter Simulation BernardoMoguel González Moderator Mexico MayuriTrivedi Moderator mayuritrivedi80@gmail.comIndia ToshihideNaganuma Moderator Japan VandanaNiyyar Moderator United States Introduction BernardoMoguel González Speaker Mexico 503
1:05 p.m. 1:10 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Closing Remarks and Next Steps Speaker: Ifeoma Ulasi, ISN AWG Chair 315
2 p.m. 3:30 p.m.	Plenary Lecture 1: Donald Seldin Lecture - Dynamics of the Function and Regulation of the Endoplasmic Reticulum and WCN'26 Opening Ceremony (Kazutoshi Mori, Japan) Jean Hamburger Award MarcelloTonelli Moderator Canada MasaomiNangaku Moderator Japan SunitaBavanandan Moderator Malaysia KornchanokVareesangthip YN Host Thailand KazutoshiMori Speaker Japan TakashiKadowaki Speaker Japan Welcome and ISN Presidential Address MarcelloTonelli Speaker Canada Jean Hamburger Award Presentation Welcome Speech by JSN President MasaomiNangaku Speaker Japan Welcome Speech by APSN President XueqingYU Speaker China Welcome Speech by SPWG Chair Sydney Tang Speaker Hong Kong, China Welcome Speech by the President of Japanese Medical Science Federation and Japanese Association of Medical Science TakashiKadowaki Speaker Japan Dynamics of the Function and Regulation of the Endoplasmic Reticulum KazutoshiMori Speaker Japan ISN Film Event Winner Presentation Main Hall
3:45 p.m. 4:45 p.m.	The Gut–Kidney Axis in CKD: Mechanistic Insights and Therapeutic Perspectives Elliot KorantengTannor Moderator Ghana YosukeHirakawa Moderator Japan The Gut as a Central Hub of Inter-Organ Cross-Talk in Chronic Kidney Disease LaetitiaKoppe Speaker France Deciphering Gut Dysbiosis: Is It Age or Kidney Disease? JohannesHolle Speaker Germany Inflammation Under Neural Control: The Gut-Brain-Kidney Triad in Acute Kidney Injury ShinjiTanaka Speaker Japan Q&A 301 - 302														Cutting Edge Science in Nephrotic Syndrome/FSGS KenjiIshikura Moderator Japan Genetics of Nephrotic Syndrome and FSGS DanielGale Speaker United Kingdom Immunology of Podocyte Injury: Nephrotic Syndrome and FSGS Hans-JoachimAnders Speaker Germany New Translational Insights in B-cell Targeted Therapies in Nephrotic Syndrome/FSGS NicolaTomas Speaker Germany Q&A Session 303														AI in Kidney Care: From Predictive Models to Pathology Support Korean Society of Nephrology Named Session Hyeong Cheon Park Moderator amp97@yuhs.acKorea Predicting, Preventing, and Saving Lives: AI Applications in AKI within the Saving Young Lives Framework MignonMcCulloch Speaker South Africa Using AI to Predict AKI in Critical Care Nephrology Yu HuiZHANG Speaker zhangyuhui9107@foxmail.comChina AI-enhanced Analysis of Kidney Biopsies IsaoMatsui Speaker Japan Q&A 304														Expanding Kidney Care Access Through Non-physician Workforce Models Becky MingyaoMa Moderator Hong Kong, China Tae WonYi Moderator Canada Non-physician Healthcare Models in CKD Care: What They Are and How to Build Them Carmen ElenaCervantes Speaker United States Empowering Primary-level Healthcare Providers Through Targeted Kidney Health Education: Lessons from India PritiMeena Speaker India Survey of Non-physician Healthcare Workers on Early CKD Detection: Preliminary Results Ana CatalinaAlvarez Elias Speaker anacatalina.alvarezelias@rriny.comUnited States Expanding CKD Care Capacity Using Non-physician Providers in Fiji Yogeshni Chandra Speaker Fiji Building Community Kidney Care in Nigeria Through Non-physician Healthcare Workers ChimezieOkwuonu Speaker Nigeria Curated Discussion 311 - 312														ISN-WIN- WIN India-WIN Africa Joint Session: Bridging the Gap: Addressing Gender Disparities in Kidney Health MalaSachdeva Moderator United States Women in Nephrology (WIN): Breaking Barriers in Kidney Health - Gender Disparities in CKD and Dialysis MalaSachdeva Speaker United States WIN-India: The Social Construct of Organ Donation -Are Women Forced to Donate? PriyamvadaP S Speaker India WIN-Africa: Trials And Tribulations: Improving Randomized Controlled Trials- How Reporting Outcomes By Sex/gender Can Make A Difference, And Barriers To Inclusion KhalidaBulhan - Soki Speaker Kenya Q&A 313 - 314														Advancing Sustainable Kidney Care: Evidence and Implementation IkechiOkpechi Moderator Canada The Latest Evidence on the Environmental Impact of Kidney Care VivekanandJha Speaker India Sustainable Kidney Care Using the GREEN-K Toolkit Winston Wing ShingFung Speaker Hong Kong, China Greening Kidney Care in Low- and Middle-income Countries MohamedBen Hmida Speaker Tunisia Q&A Session 315														The Future of AKI Care: New Therapies, Recovery Paradigms, and Global Equity Chinese Society of Nephrology Named Session XiaoqiangDing Moderator China Global Burden of AKI: Challenges and Barriers NattachaiSrisawat Speaker nattachai.sr@chula.ac.thThailand AKI and proteinuria Chi-yuanHsu Speaker United States Novel Treatments in Septic Acute Kidney Injury Kent Doi Speaker Japan New Strategies to Promote Recovery After AKI MarliesOstermann Speaker United Kingdom Q&A 501 - 502														CKD-MBD in Practice: Challenges, Controversies, and Consensus HirotakaKomaba Moderator Japan MarieEvans Moderator Sweden VivekKumar Moderator India The Evolving Biology of CKD-MBD: Implications for Clinical Care MarcVervloet Speaker Netherlands Key Outcomes From the KDIGO CKD-MBD Controversies Conference HirotakaKomaba Speaker Japan Growing Up With Chronic Kidney Disease-Mineral and Bone Disorder: Pediatric Challenges RukshanaShroff Speaker United Kingdom Q&A Session 503														HIT! High Impact Clinical Trials 1 DavidWheeler Moderator United Kingdom KatherineTuttle Moderator United States REMODEL Trial Overview: Framework and Key Outcomes PetterBjornstad Speaker United States Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial DavidCherney Speaker Canada Aldosterone Blockade for Health Improvement Evaluation in End-stage Renal Disease Trial (ACHIEVE) MichaelWalsh Speaker Canada B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil JulienHogan Speaker France Q&A Session Main Hall
5 p.m. 6:30 p.m.	Welcome Event Exhibition Hall																																																															Young Nephrologists Quiz-a-Thon IV: Japan edition Spotlight Stage 2
5:30 p.m. 6:30 p.m.	Poster Presentation Exhibition Hall
6 p.m. 6:45 p.m.	Spotlight on ISN-GKHA: Tracking a Decade of Global Kidney Health Progress Tracking the Evolution of Kidney Health Systems: Insights from ISN-GKHA 2017–2023 GeorginaIrish Speaker Australia From Data to Action: How the ISN-GKHA Map Drives Policy and Advocacy MarinaWainstein Speaker Argentina Looking Ahead: Priorities and Plans for the ISN-GKHA 2027 Edition AminuBello Speaker Canada Spotlight Stage 1																																																															ISN Community Film Event: Kidney Stories from Around the World Spotlight Stage 2

29 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 5 HiddoLambers Heerspink Moderator Netherlands NaokiKashihara Moderator kashinao@med.kawasaki-m.ac.jpJapan Clinical Impacts and Importance of Minimizing Drug Approval Delay NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan HCE (hierarchical composite end points) and eGFR slope, as potential solutions to delays in approval HiddoLambers Heerspink Speaker Netherlands Bridging Academia and Regulators in Kidney Drug Development: Insights from Japan MototsuguTanaka Speaker Japan Panel Discussion DustinLittle Moderator United States HiddoLambers Heerspink Speaker Netherlands MototsuguTanaka Speaker Japan NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 301 - 302																												Industry Symposium 3 AkiraNishiyama Moderator Japan MarikoMiyazaki Moderator mamiyaza@venus.dti.ne.jpJapan Urinary Uric Acid Excretion and Kidney Outcome YOSHITAKAISAKA Speaker Japan Uric Acid and Progression of DKD JunWada Speaker Japan 304																												Industry Symposium 1 MasaomiNangaku Moderator Japan Advanced Data Science in CKD Management YuichiroYano Speaker y.yano@juntendo.ac.jpJapan An Integrated Approach to Cardio-Renal-Metabolic Disorders : Addressing Hypertension and Dyslipidemia KOUICHITAMURA Speaker Japan 315																												Industry Symposium 6 Jonathan Barratt Moderator United Kingdom What makes IgA pathogenic in IgA nephropathy? YusukeSuzuki Speaker Japan The role of B Cells in IgA nephropathy HeatherReich Speaker Canada Targeting pathogenic IgA in IgA nephropathy Jonathan Barratt Speaker United Kingdom 501 - 502																												Industry Symposium 4 Tak Mao, DanielChan Moderator dtmchan@hku.hkHong Kong, China Intestinal Phosphate Absorption Mechanisms UpToDate -Tenapanor and Future Perspectives- HirokoSegawa Speaker Japan CKD-MBD Guideline Revision in Japan: The Journey and Global Implications HirotakaKomaba Speaker Japan 503																												Industry Symposium 2 KaoriHayashi Moderator Japan Impact of Anti-Nephrin Antibodies: An Updated Understanding of the Pathogenesis of Nephrotic Syndrome TomokoHorinouchi Speaker tomoko.hatono@gmail.comJapan Recent Advances in Immunosuppressive Therapy for Refractory Nephrotic Syndrome in Children RikuHamada Speaker Japan 303
9:25 a.m. 10:55 a.m.	Hypertension Updates: New Rules, Tools, Paths and Plans Seung HyeokHan Moderator South Korea TaraChang Moderator United States New Rules: Global Updates in Blood Pressure Guidelines TaraChang Speaker United States What Nephrologists Need to Know About Novel Antihypertensive Treatments Seung HyeokHan Speaker South Korea Implementing the Global Hearts Program to Improve Population Blood Pressure Control SwapnilHiremath Speaker Canada Optimizing Hypertension Management Across the Lifespan Magdalena Madero Speaker Mexico Q&A 301 - 302																								ISN - APSN Joint Session Sydney Tang Moderator Hong Kong, China IgA Nephropathy Study: Current and Perspective XueqingYU Speaker China Optimizing Management of Lupus Nephritis – The Clinical, The Bytes and The Bench DesmondYap Speaker Hong Kong, China From Data to Discovery: Insights from ADPKD Registries Across the Asia-Pacific KornchanokVareesangthip Speaker Thailand Genetics of Chronic Kidney Disease in East Asians YukaSugawara Speaker Japan Q&A 303																								Dissecting the Kidney in Space: From Molecules to Microenvironments MarekKollar Moderator Czech Republic PierreRonco Moderator France Applying Spatial Transcriptomics to Kidney Disease BernhardDumoulin Speaker United States A Systems Biology Approach to Tissue Mapping MatthiasKretzler Speaker United States Kidney Tissue Specific Gene Targeting TobiasHuber Speaker Germany Envision Clinical Application AgnesFogo Speaker United States Q&A 304																								Big Data Lab: Using Open Kidney Disease Data Resources for Research MatthiasKretzler Moderator United States Pathomic-driven Tissue Interrogation: Harnessing Collaborative Intelligence and Data Integration for Diagnostic Innovation LauraBarisoni Speaker United States Integrating Multiscale Data to Decode Kidney Disease Mechanisms NilsGehlenborg Speaker United States Nephroseq for Global Kidney Data Mining HeatherAscani Speaker United States The tranSMART data warehouse and analytics environment for Kidney Translational Research. Intro to user-centric software design for the Kidney Precision Medicine Project NikkiBonevich Speaker United States Exploring Single-cell and Spatial Datasets Using the Kidney Precision Medicine Project Atlas and Atlas Explorer FadhlAlakwaa Speaker United States CELLxGENE an open-source platform that empowers users to explore, annotate, analyze, and download single cell data sets VijiNair Speaker United States Q&A 315																								ISN-KDIGO Joint Session: Implementing Updated KDIGO AKI/AKD Guidelines Worldwide Kent Doi Moderator Japan Key Changes in AKI and AKD Definitions and Prognosis SamiraBell Speaker United Kingdom Identifying and Preventing AKI and AKD in High-risk Scenarios MarliesOstermann Speaker United Kingdom Clinical Management of Acute Kidney Injury and Acute Kidney Disease VivekanandJha Speaker India Optimizing Kidney Replacement Therapy in Acute Kidney Injury and Acute Kidney Disease NattachaiSrisawat Speaker Thailand Q&A 501 - 502																								B Cell Targeting in Glomerular Disease YusukeSuzuki Moderator Japan A Role for Kidney Resident B/plasma Cells in Kidney Disease Progression? HeatherReich Speaker Canada B Cell Activating Factor and A Proliferation-inducing Ligand Signaling in Glomerular Disease HongZhang Speaker China B Cell Targeted Therapies in Glomerular Diseases RichardLafayette Speaker United States The Future of B Cell Therapies in the Treatment of Glomerular Diseases Jonathan Barratt Speaker United Kingdom Q&A Session 503																								HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials AdeeraLevin Moderator Canada Andrea Viecelli Moderator Switzerland RobertoPecoits-Filho Moderator United States RESOLVE Trial: Sodium Concentration in Dialysis Populations — a Global Cluster Randomized Study MegJardine Speaker Australia Q&A Key Aspects of the VOICE Clinical Trial on Anemia in Dialysis Patients ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States Q&A The Renal Life Cycle: Development, Maturity, and Decline HiddoLambers Heerspink Speaker Netherlands Q&A Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far Joint Presentation Selvin Sundar RajMani Speaker India SuceenaAlexander Speaker India Q&A ASPIRE Trial: Aspirin Use in Dialysis Patients in China XueqingYU Speaker China Q&A Main Hall
11 a.m. 11:45 a.m.	Big Data Lab 1 - Nephroseq 321																																																								Industry Spotlight Session 10+12 SHOICHIMARUYAMA Moderator Japan A Snapshot of aHUS SHOICHIMARUYAMA Speaker Japan The aHUS Clinical Picture AnujaJava Speaker United States Highlighting AHUS Associated With Triggers WaiLim Speaker Australia Q&A Spotlight Stage 1																																																								Industry Spotlight Session 9 HidetoshiKanai Moderator Japan Translating Intention into Action: Growing and Sustaining Home Dialysis Program HidetoshiKanai Speaker Japan Q&A Session HidetoshiKanai Speaker Japan Spotlight Stage 2
11:35 a.m. 12:35 p.m.	Plenary Lecture 2: Podocytopathies: Knowns and Unknowns (Paola Romagnani, Italy) Bywaters Award AkiraNishiyama Moderator Japan LizLightstone Moderator United Kingdom Sydney Tang Moderator Hong Kong, China Ming-YanJiang YN Host Taiwan PaolaRomagnani Speaker Italy Bywaters Award Presentation Podocytopathies: Knowns and Unknowns PaolaRomagnani Speaker Italy Main Hall
12:45 p.m. 1:30 p.m.	The Global Shortage of Renal Nurses Ana Elizabeth Figueiredo Moderator Brazil Spotlight Stage 1
12:50 p.m. 1:50 p.m.	Industry Symposium 17 YusukeSuzuki Moderator Japan Exploring the Role of APRIL in IgA Nephropathy: Pathogenesis to Progression Chee KayCheung Speaker United Kingdom HeatherReich Speaker Canada 301 - 302																												Industry Symposium 14 VivekanandJha Moderator India Pathophysiology and Emerging Targeted Therapies in IgAN Yoshihito Nihei Speaker Japan Disease Pathways and Emerging Therapeutic Strategies in Primary Membranous Nephropathy VivekanandJha Speaker India Mechanism-Based Therapeutic Advances in AMR in Kidney Transplantation SteveChadban Speaker Australia 303																												Industry Symposium 15 EdwinaBrown Moderator United Kingdom A Patient’s Perspective: What Shared Decision-Making Really Means for Me TsutomuFuruzono Speaker furuzono@waka.kindai.ac.jpJapan Why SDM in Dialysis Still Falls Short: Understanding the Gaps YasuhiroKomatsu Speaker Japan Breaking Through Barriers: Practical Strategies to Make Shared Decision-Making Work EdwinaBrown Speaker United Kingdom 304																												Industry Symposium 13 KeiFukami Moderator Japan The Importance of Guideline Directed Therapy Christoph Wanner Speaker Germany Long-term Management of Hyperkalemia with Safety NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 315																												Industry Symposium 18 ShigeruShibata Moderator Japan Hypertension Management Aimed at Achieving Target Blood　Pressure : The Clinical Utility of Mineralocorticoid Receptor Antagonists HajimeNagasu Speaker Japan 501 - 502																												Industry Symposium 16 MotokoYanagita Moderator Japan Welcome & Introduction MotokoYanagita Speaker Japan Orchestrating Excellence: KDIGO’s Guidance on the Management of IgA Nephropathy Sydney Tang Speaker Hong Kong, China Setting the Tempo: The Importance of Early Diagnosis and Treatment in IgA Nephropathy Maria JoseSoler Speaker Spain A Harmonious Approach: Simultaneously Targeting Both Drivers VladoPerkovic Speaker Australia A Note of Hope: Reimagining the Outcomes for Patients With IgA Nephropathy MotokoYanagita Speaker Japan Summary & Close MotokoYanagita Speaker Japan 503
1:30 p.m. 2 p.m.	The Dialysis Games RashaDarwish Speaker Egypt SourabhSharma Speaker India Spotlight Stage 2
2:10 p.m. 3:10 p.m.	Home Dialysis Revolution: Implementation Strategies and Outcomes AdrianLiew Moderator Singapore Overcoming Barriers to Peritoneal Dialysis Implementation: The Role of the International Home Dialysis Consortium SimonDavies Speaker United Kingdom Does Home Dialysis Improve Patient Outcomes? ChristopherChan Speaker Canada Beyond Traditional Boundaries: Wearable Artificial Kidneys and Portable Dialysis Technologies MarjorieFoo Speaker Singapore Q&A 301 - 302																					ISN-PKD Foundation Joint Session - the future of PKD research and care VicenteTorres Moderator United States Introduction of the Lillian Jean Kaplan Prize for PKD & Award Presentation VicenteTorres Moderator United States Kaplan Prize winner: Disease modifying drugs for ADPKD: a rapidly evolving field. RonaldGansevoort Speaker Netherlands Platform trials in PKD: Opportunities and Challenges MegJardine Speaker Australia Is There a Role for SGLT2 Inhibitors and GLP Analogues in Treating PKD MichelChonchol Speaker United States Q&A 303																					Why Primary and Community Care Matter for Kidney Health Named Session by the Indian Society of Nephrology (Indian SN) Shyam BihariBansal Moderator India Magdalena Madero Moderator Mexico Community-based Primary Care CKD Detection and Management in Thailand TalerngsakKanjanabuch Speaker Thailand Group-based Care Models for Chronic Kidney Disease: A Latin American Perspective PaulaMarioli Speaker Argentina Roundtable Discussion 304																					ISN-WKD Joint Session: Kidney Health for All — Caring for People, Protecting the Planet DinaAbdellatif Moderator Egypt Li-LiHsiao Moderator United States ManjushaYadla Moderator India Key Takeaways from the 2026 WKD Editorial: Shaping the Future of Kidney Health DinaAbdellatif Speaker Egypt Kidney Health and Planetary Health: An Intricate Relationship NatarajanGopalakrishnan Speaker India How the Patient Voice Shapes Kidney Care and Research NicoleScholes-Robertson Speaker Australia Driving Change in Kidney Care: Lessons and Tools That Work Augusto CesarSoares dos Santos Junior Speaker Brazil Q&A 315																					ISN - EASD Joint Session: Crossroads of Nephrology and Diabetes: From Bench to Bedside ImariMimura Moderator Japan JuliaMader Moderator Australia Modern Management of Diabetic Kidney Disease: From Early Detection to Precision Therapy JanakaKaralliedde Speaker United Kingdom Beyond HbA1c: Continuous Glucose Monitoring in Kidney Disease Care JuliaMader Speaker Australia Drug Development in Diabetic Kidney Disease PeterRossing Speaker Denmark Q&A 501 - 502																					Rare Kidney Disease Update KatherineTuttle Moderator United States Understanding IgA Nephropathy Today HeatherReich Speaker Canada Advances in C3G Diagnosis and Treatment HernánTrimarchi Speaker Argentina Atypical Hemolytic Uremic Syndrome: Current Concepts and Management DavidKavanagh Speaker United Kingdom Lupus Nephritis LizLightstone Speaker United Kingdom Q&A 503																					HIT! High Impact Clinical Trials 3 In IgA Nephropathy HeatherReich Moderator Canada Sydney Tang Moderator Hong Kong, China YusukeSuzuki Moderator Japan Opening & Introduction Sydney Tang Speaker Hong Kong, China Efficacy and Safety Results of Atrasentan in Patients With IgA Nephropathy on Sodium‚ äìglucose Co-transporter 2 Inhibitors: Phase II, Randomized, Placebo-controlled, Crossover Trial (Assist) HiddoLambers Heerspink Speaker Netherlands Q&A Efficacy and Safety of a Targeted-release Formulation of Budesonide (HR19042 Capsules) in Patients With Primary IgA Nephropathy: A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2/3 Trial XiaobingYang Speaker China Q&A Efficacy and Safety of Iptacopan in Patients With IgA Nephropathy (IgAN): Final 24-month Results From the Phase III APPLAUSE-IgAN Study VladoPerkovic Speaker Australia Q&A Closing Remarks Main Hall																					Industry Spotlight Session 20 PeterZipfel Moderator Germany BerndJilma Speaker Austria Spotlight Stage 1
2:30 p.m. 3 p.m.	Industry Spotlight Session 19 DavidCherney Moderator Canada Welcome and introduction DavidCherney Moderator Canada More than CKD: identifying and managing CV risk in patients With CKD DavidCherney Speaker Canada Audience Q&A DavidCherney Moderator Canada Toshiyuki Ko Moderator Japan From the kidneys to the heart: practical management tools for CV risk in patients with CKD Toshiyuki Ko Speaker Japan Audience Q&A DavidCherney Moderator Canada Toshiyuki Ko Moderator Japan Summary and close DavidCherney Moderator Canada Spotlight Stage 2
3:15 p.m. 4 p.m.	Big Data Lab 2 - Kidney Tissue Atlas 321																																																																Industry Spotlight Session 21 HironoriKobayashi Moderator Japan Utilizing Remote Patient Management in PD Treatment: Sharesource & MyPD Enables Team-Based Care and Healthcare Collaboration HironoriKobayashi Speaker Japan Q&A Session HironoriKobayashi Speaker Japan Spotlight Stage 2
3:50 p.m. 4:50 p.m.	Industry Digest: Insights into Latest Innovations from Scientific Leads Advancing the Next Wave of Therapies in Chronic Kidney Disease DustinLittle Speaker United States Effects of Finerenone on Biomarkers: Mechanistic Insights From Proteomic Analyses in Clinical Trials MarioBerger Speaker mario.berger@bayer.comGermany Future Directions in CRM Care: Advancing Research and Therapeutic Innovation AntonioGarreta Rufas Speaker Germany Innovative Strategies for Clinical Trial Design in IgAN LokeshShah Speaker United States Improving Outcomes in Complement-mediated Kidney Diseases Marianne Silkjær Nielsen Speaker Switzerland Advancing Mechanistic Trials through Industry–Academia Collaboration: Insights from the REMODEL Trial ManuelMayrdorfer Speaker Denmark Why? When? How? How to Maximize Patient Outcomes From the Start of Dialysis PeterRutherford Speaker Switzerland 301 - 302																								Building Trust and Equity in Indigenous Transplant Care SamanthaBateman Moderator Australia Return to Country: Evaluating Health Service Bias and the Impact of Place-based Cultural Safety Initiatives KelliOwen Speaker Australia ScottJones Speaker Australia Equity in Action: Improving Access to Kidney Transplantation Through Community Partnerships in Rural, Remote, and Indigenous Communities AnuragSingh Speaker Canada Celebrating Cultural Inclusion and Safety in Academia and Medical Education LukeWilson Speaker New Zealand Q&A 303																								ISN-ISGD Joint Session KeizoKanasaki Moderator kkanasakidr@gmail.comJapan Autoantibodies Targeting Podocyte-specific Antigens in Primary Nephrotic Syndrome TobiasHuber Speaker Germany Insights from the Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) groups AlessiaFornoni Speaker United States Podocyte-directed Progression of Kidney Injury in FSGS and DKD John CijiangHe Speaker United States Q&A 304																								Navigating Ethical Challenges in End-of-Life Kidney Care DominiqueMartin Moderator Australia Building Trust and Hope in Kidney Failure Care NoriakiKurita Speaker Japan How Advance Care Planning Supports Kidney Care Decisions KathrynDucharlet Speaker Australia Patient Involvement in Shaping End-of-Life Kidney Care Policies ManvirVictor Speaker Malaysia Q&A 315																								Innovating Kidney Trials: PROMs, New Designs, and Global Roadmaps AdeeraLevin Moderator Canada MasaomiNangaku Moderator Japan Opening Remarks and Session Overview AdeeraLevin Speaker Canada Overcoming the Bottleneck: Endpoint Selection in Phase 2 Kidney Trials Kai-UweEckardt Speaker Germany Integrating Patient-Reported Outcomes (PROMs) Using Patient-reported Outcomes to Improve Kidney Research and Care AllisonJaure Speaker Australia AnastasiaHughes Speaker Australia ChandanaGuha Speaker Australia Rethinking Kidney Trials: Innovative Designs for Modern Research Questions MegJardine Speaker Australia Designing Better Kidney Trials Using Hierarchical Composite Endpoints HiddoLambers Heerspink Speaker Netherlands Panel Discussion & Q&A Closing Remarks MasaomiNangaku Speaker Japan 501 - 502																								Paediatric Transplantation: Identifying Patients at Risk GloriaAshuntantang Moderator Cameroon What Will Be the Future of Personalised Immunosuppression in Children? LarsPape Speaker Germany Can We Prevent FSGS Recurrence in Children? PriyaVerghese Speaker United States What Is the Role of Anti-Nephrin Antibody in Pediatric Kidney Transplantation? YukoHamasaki Speaker Japan Q&A 503																								Hot Debate: Friend or Foe: SUMOylation in Kidney Injury and Repair ShigeruShibata Moderator Japan SUMOylation of Podocin Reverses the Progression of Diabetic Kidney Disease PedroGeraldes Speaker Pedro.Geraldes@USherbrooke.caCanada SUMOylation Activates β-Catenin and Contributes to Kidney Fibrosis ZhengDong Speaker United States Main Hall
5 p.m. 6 p.m.	Industry Symposium 26 YusukeSuzuki Moderator Japan Evolving Landscape of IgA Nephropathy in 2026 and Beyond HongZhang Speaker China 303																								Industry Symposium 27 HITOSHISUZUKI Moderator Japan Welcome & Introduction HITOSHISUZUKI Speaker Japan Understanding IgA Nephropathy Worldwide: Presentation, Progression, and Epidemiology ShikhaWadhwani Speaker shikha.wadhwani@northwestern.eduUnited States Mechanistic insights: Exploring the Role of Complement in IgA Nephropathy Jonathan Barratt Speaker United Kingdom Panel Discussion and Q&A Session & Closing Remarks HITOSHISUZUKI Speaker Japan 304																								Industry Symposium 25 ParthaDas Moderator United Kingdom SharleneGreenwood Moderator United Kingdom Improving ESKD outcomes in Brazil BrunoZawadzki Speaker Brazil Identifying and managing CKD in Africa KateBramham Speaker United Kingdom Q&A 315																								Big Data Lab 3 - CELLxGENE 321																								Industry Symposium 30 YOSHITAKAISAKA Moderator Japan Transformative Insights from the DAPA-CKD Trial: Lessons for the Future of Kidney Care NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 501 - 502																								Poster Presentation Exhibition Hall																								From Seed to Impact: Building Global Kidney Care Capacity through ISN Grants RobertWalker Moderator New Zealand TakashiKobayashi Speaker Japan FarnazNobi Speaker Bangladesh AhadQayyum Speaker Pakistan Spotlight Stage 1
5:15 p.m. 6:15 p.m.	The Kidney Tank 3.0 - The Japanese Version SwapnilHiremath Speaker Canada MythriShankar Speaker India ManjushaYadla Speaker India Spotlight Stage 2
5:30 p.m. 6:15 p.m.	Your Nephrology Journey: Generalist or Specialist? AhadQayyum Speaker Pakistan Kanako Terakawa Speaker Japan NikolayBulanov Speaker Russia SabineKaram Speaker United States YannickNlandu Speaker Democratic Republic of Congo Spotlight Stage 1

30 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 35 KatherineTuttle Moderator United States Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL trial KatherineTuttle Speaker United States Multiparametric Imaging and Tissue Transcriptomics to Unravel Mechanisms of Kidney Protection MatthiasKretzler Speaker United States GLP1s in Combination With Other Therapies and Applications in Clinical Practice BrendonNeuen Speaker Australia The Future of GLP1s and Other Incretin-based Therapies for Kidney Disease MasaomiNangaku Speaker Japan 301 - 302																																																																Industry Symposium 33 JunOh Moderator Germany Welcome and introduction JunOh Speaker Germany The burden of pediatric chronic kidney disease: Epidemiology, etiology and unmet needs KenjiIshikura Speaker Japan Studying pediatric chronic kidney disease: Challenges in evidence generation and clinical research HughMcCarthy Speaker Australia The long-term consequences of childhood CKD: Growth, cardiovascular risk and adult outcomes JunOh Speaker Germany Summary JunOh Speaker Germany Discussion and Q&A 304																																																																Breakfast With the Editors: Publishing in Nephrology BradRovin Moderator United States PierreRonco Moderator France Defining Vision and Scope PierreRonco Speaker France Introducing Kidney International Clinical Reports Journal SwapnilHiremath Speaker Canada Choosing the Right Nephrology Journal PierreRonco Speaker France How Editors Assess Manuscripts BradRovin Speaker United States Responding to Reviewer Comments JaiRadhakrishnan Speaker United States Dealing With Statistics in Kidney Research GermaineWong Speaker Australia From First Draft to First Author: Perspectives From a KI Editorial Fellow GriffithPerkins Speaker Australia Panel Discussion 313 - 314																																																																Industry Symposium 31 ChristineSkerka Moderator christine.skerka@googlemail.comGermany Complement Deregulation in C3 Glomerulopathy : A Diagnostic Perspective PeterZipfel Speaker peter.zipfel@live.comGermany Targeted Therapy for C3 Glomerulopathy: Exciting Changes for Patients and Nephrologists MichaelWiesener Speaker Germany C3 Glomerulopathy: Current Concepts and Emerging Therapeutic Strategies DineshKhullar Speaker India 315																																																																Industry Symposium 36 HITOSHISUZUKI Moderator Japan Overview of Unmet Need in IgA Nephropathy and Disease Markers AdrianLiew Speaker Singapore Emerging Therapeutics Targets in IgAN: The Role of BAFF and APRIL SuceenaAlexander Speaker India Targeting BAFF and APRIL with Atacicept RichardLafayette Speaker United States 501 - 502																																																																Industry Symposium 34 SHOICHIMARUYAMA Moderator Japan Chair's welcome SHOICHIMARUYAMA Moderator Japan Evolution of C3G and primary IC-MPGN disease understanding: from molecular mechanisms to addressing patient needs EdwinWong Speaker United Kingdom A race against time: the value of an early and accurate diagnosis Seung HyeokHan Speaker South Korea Panel discussion: Looking to the future: time to support our patients SHOICHIMARUYAMA Moderator Japan Q&A and close SHOICHIMARUYAMA Moderator Japan 503
9:25 a.m. 10:55 a.m.	ISN-JSN Joint Session: Bioengineering the Kidney of the Future ReikoInagi Moderator Japan Shaping the Future of Kidney Regeneration TakashiYokoo Speaker Japan From iPS Cells to Kidneys: A Roadmap to Regeneration KenjiOsafune Speaker Japan Breakthrough Discoveries Shaping the Future of Kidney Repair YunXia Speaker Singapore Cutting-Edge Strategies in Kidney Regeneration JonathanHimmelfarb Speaker United States Q&A 301 - 302																																																																New Precision Therapies in Kidney Care Yoshihito Nihei Moderator Japan Adeno-associated Viral Therapy in Kidney Diseases HiroyukiNakai Speaker United States CAR-T Cell Therapy in Lupus BradRovin Speaker United States Cellular Immunotherapy in Kidney Transplantation TambiJarmi Speaker Jarmi.Tambi@mayo.eduUnited States Q&A 303																																																																ISN-YNC Joint Session: Youthful Insights on Aging Kidneys AhadQayyum Panel Pakistan BiancaDavidson Panel South Africa HannahBeckwith Panel United Kingdom Winston Wing ShingFung Panel Hong Kong, China A Novel Automated Immunoassay for Anti-nephrin Autoantibodies Using a Mutant Nephrin Antigen MasayaMuto Awardee Japan Targeting B Cells Upfront: Comparing Safety and Efficacy of Rituximab and Corticosteroids as a First Line Therapy in Newly Diagnosed Cases of Adult-onset Minimal Change Disease (B-ripp Study) PritiMeena Awardee India Molecular Mechanisms of Kidney Aging: From Bench to Bedside TakeshiYamamoto Speaker Japan Rethinking Goals of Care in Elderly Dialysis Patients HannahBeckwith Speaker United Kingdom Providing Care for the Aging Kidney in Low-resource Settings AhadQayyum Speaker Pakistan Synergy in Senescence: New Perspectives on Kidney Aging TakeshiYamamoto Speaker Japan 304																																																																The ISN Journals Editorial Session: The Best of 2025 KI and KI Reports Articles BradRovin Moderator United States GermaineWong Moderator Australia PierreRonco Moderator France Kidney International in Focus: Annual Highlights PierreRonco Speaker France ISN-KI Fellows: Showcasing Excellence, Part 1 — Pediatrics GabrielCara-Fuentes Speaker United States ISN-KI Fellows: Showcasing Excellence, Part 2 — Clinical Nephrology SaharKoubar Speaker United States ISN-KI Fellows: Showcasing Excellence Part 3 — Epidemiology & Clinical Trials DavidTunnicliffe Speaker Australia ISN-KI Fellows: Showcasing Excellence, Part 4 — Basic and Translational Science NahidTabibzadeh Speaker France Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker United States Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker United States Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker United States Celebrating Excellence: Best Reviewer Awards Presentation BradRovin Speaker United States Presentation of Basic Science Awards (Early Career Researcher Awards) BernhardDumoulin Speaker United States Presentation of Clinical Science Awards (Early Career Researcher Awards) Louis-CharlesDesbiens Speaker Canada ISN-KI Fellows: Where Are They Now? GermaineWong Speaker Australia 315																																																																Integrating Care for Cardiovascular-Kidney-Metabolic Health Across the Lifespan BrendanSmyth Moderator Australia Tae WonYi Moderator Canada Is Kidney Dysfunction in Heart Failure More Than Just Low Cardiac Output? BrendonNeuen Speaker Australia Is Metabolic Dysfunction in Cardiovascular-Kidney-Metabolic Syndrome More Than Just Hyperglycemia and Obesity? HiddoLambers Heerspink Speaker Netherlands Kidney at the Center of Cardiovascular-Kidney-Metabolic Syndrome MasaomiNangaku Speaker Japan What’s Next in Cardiovascular-Kidney-Metabolic Therapy? RobertoPecoits-Filho Speaker United States Q&A 501 - 502																																																																Understanding and Treating Complement-Mediated Glomerular Disease VivekanandJha Moderator India Applying Precision Medicine to Glomerular Disorders JonathanHimmelfarb Speaker United States Genetic Complementopathies and Kidney Disease AnujaJava Speaker United States Complement and IgA Nephropathy AdrianLiew Speaker Singapore Complement and Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis RosnawatiYahya Speaker Malaysia Q&A 503																																																																HIT! High Impact Clinical Trials 4 KeiFukami Moderator Japan LizLightstone Moderator United Kingdom Effect of a 12-week Intradialytic Cycling Intervention on Hemodialysis-induced Myocardial Stunning: A Multi-centre Randomized Controlled Trial ClaraBohm Speaker Canada TEACH-PD Cluster Randomized Controlled Trial: Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes JosephineChow Speaker Australia Effect of Finerenone on Circulating Biomarkers: A CONFIDENCE Analysis MarioBerger Speaker mario.berger@bayer.comGermany Effect of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-creatinine Ratio by Age and Sex in the CONFIDENCE Trial RajivAgarwal Speaker United States Estimated Glomerular Filtration Rate, Systolic Blood Pressure, and Urinary Albumin-to-creatinine Ratio — Unravelling the Interplay in Combination: Findings From the CONFIDENCE Trial RajivAgarwal Speaker United States Lowering-Hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double Blind Randomized Controlled Trial Naya Huang Speaker huangnaya@163.comChina Main Hall
11 a.m. 11:45 a.m.	Big Data Lab 4 - Digital Pathology LauraBarisoni Speaker United States 321																																																																Translating Knowledge Into Action: Implementing the ISN i3C CKDu Toolkit for Global Impact Understanding the CKDu Challenge: A Global Health Priority ErangaWijewickrama Speaker Sri Lanka Inside the ISN i3C CKDu Toolkit: Structure, Stages, and Key Components Ana CatalinaAlvarez Elias Speaker anacatalina.alvarezelias@rriny.comUnited States From Knowledge to Action: Implementing the Toolkit for Global Impact Magdalena Madero Speaker Mexico Spotlight Stage 1																																																																Industry Spotlight Session 39 JosephineChow Moderator Australia Empowering Nurses is a Key for Home Dialysis Expansion JosephineChow Speaker Australia Q & A Session JosephineChow Moderator Australia Spotlight Stage 2
11:35 a.m. 12:35 p.m.	Plenary Lecture 3: The Potential of Polypills in CKD (Anthony Rodgers, Australia) Schrier Award Presentation LilyMushahar Moderator Malaysia MotokoYanagita Moderator Japan RobertKalyesubula Moderator Uganda Marques Shek NamNg YN Host Hong Kong, China AnthonyRodgers Speaker Australia Schrier Award Presentation The Potential of Polypills in CKD AnthonyRodgers Speaker Australia Main Hall
12:45 p.m. 1:15 p.m.	Social Media Impacts Nephrology Clinical Practice CristinaPopa Speaker Romania DIVYABAJPAI Speaker India Spotlight Stage 1
12:50 p.m. 1:50 p.m.	Industry Symposium 47 BradRovin Moderator United States Intro + IgAN Case: Global Perspective BradRovin Speaker United States IgAN Case: China Perspective HongZhang Speaker China IgAN Case: Japan Perspective HITOSHISUZUKI Speaker Japan 301 - 302																																																																Industry Symposium 44 YusukeSuzuki Moderator Japan Welcome and introduction YusukeSuzuki Speaker Japan Audience pooling Chee KayCheung Speaker United Kingdom Recent guidelines updates in IgAN-The rationale Chee KayCheung Speaker United Kingdom The old and the new to approaching treatment SaynaNorouzi Speaker United States Summary and close YusukeSuzuki Speaker Japan 303																																																																Industry Symposium 45 MasaomiNangaku Moderator Japan Welcome & Introductions MasaomiNangaku Speaker Japan UACR: The hidden marker of heart and kidney risk PamelaKushner Speaker United States RobertoPecoits-Filho Speaker United States Live Q&A MasaomiNangaku Moderator Japan The Impact of RAAS Dysregulation in Cardiorenal Disease Sydney Tang Speaker Hong Kong, China Live Q&A MasaomiNangaku Moderator Japan Closing Remarks MasaomiNangaku Moderator Japan 304																																																																Industry Symposium 43 AshokSarin Moderator India Paradigm Shift in Anemia Management: From ESAs to HIF-PHIs Prem PrakashVarma Speaker India Real World Evidence with Desidustat: India's Contribution to the Global HIF Story DineshKhullar Speaker India Panel discussion - Optimizing Outcomes with HIF-PHIs in CKD Anemia ManishMalik Panel India Narayan Prasad Panel India SandipBhattacharya Panel sandipkb65@gmail.comIndia DibyaSingh Shah Panel Nepal D SBhadauria Panel speaker@doc.comIndia 315																																																																Industry Symposium 48 NaokiSato Moderator nms-ns@nms.ac.jpJapan RajivAgarwal Moderator United States Welcome & Introduction NaokiSato Speaker nms-ns@nms.ac.jpJapan Early Action, Stronger Protection BrendonNeuen Speaker Australia Lower UACR, Optimized Outcomes RajivAgarwal Speaker United States Finerenone, a CKM Pillar Jozineter Maaten Speaker Netherlands Changing Trajectories in Practice KeizoKanasaki Speaker kkanasakidr@gmail.comJapan Q&A and Closing Remarks / Panel Discussion NaokiSato Speaker nms-ns@nms.ac.jpJapan RajivAgarwal Speaker United States 501 - 502																																																																Industry Symposium 46 YOSHITAKAISAKA Moderator Japan Welcome and introduction YOSHITAKAISAKA Moderator Japan Pathophysiology of C3G and Importance of Early Diagnosis YOSHITAKAISAKA Moderator Japan Case studies: Different Patient Profiles CarlaNester Speaker United States DavidKavanagh Speaker United Kingdom Paul Brinkkötter Speaker paul.brinkkoetter@uk-koeln.deGermany Guidelines and Redefining Standard of Care YOSHITAKAISAKA Moderator Japan Audience Q&A YOSHITAKAISAKA Moderator Japan Summary and close YOSHITAKAISAKA Moderator Japan 503
1 p.m. 2 p.m.	ISN Program Awards RobertWalker Moderator New Zealand Henry H LWu Awardee Australia SukanyaGovindan Awardee India PriyaPais Awardee India PhuTran Nguyen Trong Awardee Vietnam Spotlight Stage 2
1:15 p.m. 2 p.m.	What Patients Tells Nurses (and Not Doctors) RachaelWalker Moderator New Zealand Spotlight Stage 1
2:10 p.m. 3:10 p.m.	Onco-nephrology: Navigating the Complexities of Kidney Disease in Patients With Cancer AnuragSingh Moderator Canada BhavnaBhasin-Chhabra Moderator United States Cancer Screening in Kidney Transplant Recipients and Dialysis Patients Chi Yuen SimonCheung Speaker Hong Kong, China Chronic Kidney Disease After Childhood Cancer Maria JoseSoler Speaker Spain Roundtable Discussion 301 - 302																																																								Pregnancy and Kidney Disease: A Rapid-fire Clinical Update ISN Train the Trainer Program MichelleHladunewich Moderator Canada ShilpanjaliJesudason Moderator Australia ISN Train-the-Trainer Program Overview ShilpanjaliJesudason Speaker Australia Rapid Fire Update 1 BalaWaziri Speaker Nigeria Rapid Fire Update 2 RashaShemies Speaker Egypt Q&A MichelleHladunewich Moderator Canada 303																																																								ISN-YNC Session: Hot Debate: Can Xenotransplants and Stem Cells Replace Human Organ Donation? KornchanokVareesangthip Moderator Thailand Introduction Proposition Speech 1 UgochiOnu Speaker Nigeria Opposition Speech 1 HirakuTsujimoto Speaker Japan Rebuttal and Proposition Speech 2 I-RuChen Speaker Taiwan Rebuttal and Opposition Speech 2 Milagros MelissaFlores Fonseca Speaker Mexico Audience Participation And Questions From Judges KenjiMatsui Judge United States NihalBashir Judge United Arab Emirates Voting and Summary Announcement of Winner and Prize Presentation 304																																																								A Turning Point for Kidney Health: Global Impact of the WHO Resolution IfeomaUlasi Moderator Nigeria Sydney Tang Moderator Hong Kong, China Implementing the WHO Resolution on Kidney Health MarcelloTonelli Speaker Canada From Resolution to Reality: Translating Evidence-Based CKD Therapies into Health Systems DavidWheeler Speaker United Kingdom Panel Discussion 313 - 314																																																								World Veterinary Association BernardoMoguel González Moderator Mexico Structure and Function of the Feline Kidney: Clinical Perspectives on Disease Development TakakoShimokawa Speaker Japan Animal Model–Based Training and Success in Interventional Nephrology BernardoMoguel González Speaker Mexico Physiological Functions of a Cetacean-specific Aquaporin MiwaSuzuki Speaker Japan Q&A 315																																																								Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk? Magdalena Madero Moderator Mexico Complement Inhibition Should Be Considered Before Nefecon in Patients With IgAN at Risk of Progression VladoPerkovic Speaker Australia Nefecon Should Be Considered Before Complement Inhibition in Patients With IgAN at Risk of Progression HongZhang Speaker China 501 - 502																																																								ISN-ISPD Joint Session: Peritoneal Dialysis for Everyone, by Everyone, Everywhere Ana Elizabeth Figueiredo Moderator Brazil LilyMushahar Moderator Malaysia Supporting Patients in Choosing Peritoneal Dialysis as a Treatment Option RajnishMehrotra Speaker United States Person-centered Multidimensional Support for Patients on Home Dialysis RachaelWalker Speaker New Zealand Peritoneal Dialysis for Older Adults With Kidney Failure EdwinaBrown Speaker United Kingdom Hybrid Dialysis Models for Long-term Kidney Replacement Therapy YasuhikoIto Speaker Japan Q&A 503																																																								Advances in CKD: in collaboration with the Lancet AdeeraLevin Moderator Canada JenniferLees Moderator United Kingdom MidoriSakashita Moderator Japan Advances in the Diagnosis and Detection of CKD LuxiaZhang Speaker China Advances in Understanding the Impact of Sex on Kidney Health and Disease KateStevens Speaker United Kingdom Advances in CKD Therapeutics in the Context of Complex Disease Interactions AndrejSkoberne Speaker Slovenia Q&A Main Hall																																																								Industry Spotlight Session 50 Atul DattatreyaSajgure Moderator atulsajgure@yahoo.comIndia JavedVakil Moderator jmvakvakil@gmail.comIndia T Balasubramaniyan Speaker mmcnephro@gmail.comIndia SiddharthLakhani Speaker India Neuropathic Pain in CKD and Dialysis T Balasubramaniyan Speaker mmcnephro@gmail.comIndia Current and Emerging Therapies for Peripheral Neuropathy in CKD & Dialysis SiddharthLakhani Speaker India Spotlight Stage 1
3:15 p.m. 4 p.m.	Big Data Lab 5 - Kidney Precision Medicine Project - KPMP Atlas 321																																																																Squid Game Season 2: A Thrilling Game to Learn Kidney Genetics DanielO'Hara Moderator Australia Becky MingyaoMa Moderator Hong Kong, China Spotlight Stage 1																																																																Industry Spotlight Session 51 RajivAgarwal Moderator United States The Pillar Perspective: A Deep Dive Into Clinical Evidence RajivAgarwal Speaker United States Panel Discussion Multimodal Management of CKD and HF RajivAgarwal Moderator United States Jozineter Maaten Panel Netherlands NaokiSato Panel nms-ns@nms.ac.jpJapan Spotlight Stage 2
3:50 p.m. 4:50 p.m.	From Ground Zero: Building Kidney Transplant Programs in Resource-limited Settings IkechiOkpechi Moderator Canada LilyMushahar Moderator Malaysia Paediatric Transplantation in LMICs: Building Family-Centered Infrastructure PriyaPais Speaker India Against the Odds: Establishing a Hospital-Based Transplant Program in Cameroon GloriaAshuntantang Speaker Cameroon Collaboration and Commitment: Malaysia's Journey Toward Transplant Independence Muhammad IqbalAbdul Hafidz Speaker Malaysia Q&A 301 - 302																																																															The Global Kidney Health Atlas: Advancing Equity and Excellence in Kidney Care Worldwide AdeeraLevin Moderator Canada MegJardine Moderator Australia Opening & Session Introduction AdeeraLevin Moderator Canada Tracking Kidney Care Capacity: The ISN-Global Kidney Health Atlas 2025 Update SomkanyaTungsanga Speaker Canada Regional Perspectives: Gaps and Successes in Kidney Care Delivery ArpanaIyengar Speaker India Innovation & Collaboration for Better Kidney Health AminuBello Speaker Canada Future Directions: Questions and Closing Remarks HiroshiNishi Speaker Japan 303																																																															ISN-IPNA session KenjiIshikura Moderator Japan RulanParekh Moderator Canada Emerging Treatments for Pediatric Nephrotic Syndrome KoichiNAKANISHI Speaker Japan Therapies for Nephrotic Syndrome: Short‑Term Impact, Long‑Term Promise Identify opportunities to integrate short‑term treatment gains with long‑term management strategies RulanParekh Speaker Canada What Clinicians Should Know About Anti-CD20 Monoclonal Antibodies in Childhood Nephrotic Syndrome Eugene Yu HinChan Speaker Hong Kong, China Q&A 304																																																															Autoantibody-mediated Kidney Disease PeterZipfel Moderator peter.zipfel@live.comGermany Anti-nephrin Mediated Podocytopathy Felicitas E.Hengel Speaker Germany PLA2R Epitope Pairing is Essential for Complement Activation in Membranous Nephropathy Cheng-LungKu Speaker Taiwan What’s New in Anti-GBM Antibody Research Ming-huiZhao Speaker China Q&A 313 - 314																																																															ISN–DICG Joint Session: Confronting Organ Trafficking — Policy, Ethics, and Prevention GloriaAshuntantang Moderator Cameroon YADIRA ANTONIATEHUACANERO TECUA Moderator Mexico Mandatory Reporting of Suspicious Transplant-related Cases Maria AmaliaMatamoros Speaker Costa Rica Incentives to Reduce Organ Shortage KhalidaBulhan - Soki Speaker Kenya Addressing Inequities to Prevent Organ Trafficking and Transplant Tourism LiliaCervantes Speaker United States Q&A 315																																																															Glomerular Disease Beyond the Kidney: Extraglomerular Manifestations BeatrizFernandez-Fernandez Moderator Spain DavidWheeler Moderator United Kingdom SabineKaram Moderator United States Patient-reported Outcomes in Glomerular Disease: Considering the Whole Person MichelleO'Shaughnessy Speaker Ireland Infectious Complications in Primary Glomerular Disease: Ensuring the Cure Isn’t Worse Than the Disease BalazsOdler Speaker Austria Cardiovascular Disease in Primary Glomerular Diseases: Quantifying and Reducing Risk MarkCanney Speaker Canada Q&A 501 - 502																																																															ISN-ADQI Joint Session: Implementation Science and AKI in Acute Kidney Care AnuragSingh Moderator Canada MarliesOstermann Moderator United Kingdom Why Implementation Science Matters in Acute Kidney Care YuvaramReddy Speaker United States What Is the Acute Disease Quality Initiative (ADQI) and Why Do We Need ADQI XXXV? MarliesOstermann Speaker United Kingdom What Did We Learn From ADQI XXXV? OleksaRewa Speaker Canada Q&A 503																																																															Anemia Care in CKD: Recent Evidence and Future Directions Chuan-MingHao Moderator China KDIGO Updates on Management of CKD Anemia WolfgangWinkelmayer Speaker United States Why CKD Anemia Care Differs Across Regions SunitaBavanandan Speaker Malaysia Beyond Erythropoiesis-stimulating Agents and Iron: Navigating the Future of Anemia of Chronic Kidney Disease Management Kai-UweEckardt Speaker Germany Q&A Main Hall
5 p.m. 6 p.m.	Industry Symposium 59 TakashiYokoo Moderator Japan Welcome and introduction From evidence to practice: SGLT2 inhibitors as a foundational treatment for patients With CKD BeatrizFernandez-Fernandez Speaker Spain Prompt action in CKD: increasing treatment benefits for your patients with CKD Iande Boer Speaker United States The hidden burden: managing cardiovascular risk in patients with CKD BrendonNeuen Speaker Australia Audience Q&A Summary and close 301 - 302																																																								Industry Symposium 56 MotokoYanagita Moderator Japan The Significance of Potassium Management in CKD Treatment HidekiYokoi Speaker yokoih@kuhp.kyoto-u.ac.jpJapan 303																																																								Industry Symposium 57 MasaomiNangaku Moderator Japan The Future of Lupus Nephritis: Achieving Renal Protection Through Proteinuria Control SHOICHIMARUYAMA Speaker Japan A New Era in Lupus Nephritis: Clinical Evidence and Therapeutic Positioning of Triple Therapy KeijuHiromura Speaker Japan 304																																																								Industry Symposium 55 Opening Remarks Optimal Timing of Treatment Initiation and Monitoring Strategies for Fabry Disease Patients in Korea Eun HuiBae Speaker baedak@hanmail.netSouth Korea New Therapeutic Strategies for Fabry Disease HidekiFujii Speaker Japan Discussion Closing Remarks 315																																																								Big Data Lab 6 - TBA 321																																																								Industry Symposium 58 HITOSHISUZUKI Moderator Japan Tonsillectomy for IgA nephropathy MikiTakahara Speaker miki@asahikawa-med.ac.jpJapan Impact of Intestinal Barrier Dysfunction on IgA Deposition in the Glomeruli KojiHase Speaker hase.a6@keio.jpJapan 503																																																								Poster Presentation Exhibition Hall																																																								Clinical Trials Demystified: How ISN TrialWatch and the Guide for Everyone Empower Understanding and Participation Building Clinical Trial Awareness in the Kidney Community Andrea Viecelli Speaker Switzerland ISN TrialWatch: Bringing the Latest Evidence to the Kidney Community MeganBorkum Speaker Canada The ISN Guide for Everyone: Demystifying Clinical Research AdeeraLevin Speaker Canada Spotlight Stage 1																																																								Support Your Non-Physician Kidney Care Allies: Launch of a Global Curriculum by ISN Emerging Leaders cohort 3 MythriShankar Moderator India Becky MingyaoMa Moderator Hong Kong, China MarekKollar Moderator Czech Republic Spotlight Stage 2
5:30 p.m. 6 p.m.	When Disasters Are the Norm: A 2050 Kidney Care Simulation MarinaWainstein Moderator Argentina SabineKaram Moderator United States Micro-scenario 1: Water Disruption — a 2050 Simulation Vignette SayakaIshigaki Speaker Japan Micro-Scenario 2: Digital Outage and Logistics Delay Chia-TerChao Speaker Taiwan A Set of “Resilience Provocations” for 2050 Kyung DonYoo Speaker South Korea Spotlight Stage 1																																																																Women in Nephrology: Home Dialysis Perspectives From Three Regions MalaSachdeva Moderator United States Women in Nephrology USA: Regional Experience and Insights MalaSachdeva Speaker United States Women in Nephrology in India: Progress, Barriers, and Opportunities UrmilaAnandh Speaker India Women in Nephrology in Africa: Lessons Learned KhalidaBulhan - Soki Speaker Kenya Questions and Answers Spotlight Stage 2

31 March 2026

Time	Session

8 a.m. 9 a.m.	Industry Symposium 61 MotokoYanagita Moderator Japan Revisiting MR-Mediated Electrolyte Imbalance at the Tissue Level: Implications for MR Blockade and JSH2025 Guidelines KentoKitada Speaker Japan 303
9:10 a.m. 10:40 a.m.	Kidney Health in Pregnancy: Solutions to a Growing Challenge DIVYABAJPAI Moderator India KateBramham Moderator United Kingdom Global Snapshot of Pregnancy-associated Acute Kidney Injury: Results From the 2025 Global Survey KatherineClark Speaker United Kingdom Improving Pregnancy-related Kidney Disease Diagnosis RashaShemies Speaker Egypt Emerging Strategies for CKD Care During Pregnancy DIVYABAJPAI Speaker India Q&A 301 - 302				ISN-TTS Joint Session: Maximising Opportunities and Resources in Kidney Transplant Care GeorginaIrish Moderator Australia Using Causal Inference to Study Gender Gaps in Transplant Access JessicaHarding Speaker United States Pragmatic Medicine: Learning From the Indian Experience Shyam BihariBansal Speaker India Helping Patients Manage Medications and Complex Health Systems GermaineWong Speaker Australia Reducing the Environmental Footprint in Transplantation IvoLaranjinha Speaker Portugal Q&A 303				Genetic Testing in Kidney Disease: Interpretation and Patient Perspectives RoserTorra Moderator Spain Genetic Pretesting — Is More Always Better? RoserTorra Speaker Spain The Test: Nephro-genomic Board Simulation: Variant Scientist X Genetic Nephrologist DanielGale Speaker United Kingdom Risk Alleles and Low-penetrance Variants in Nephrology: Gaps in Evidence JanewitWongboonsin Speaker Thailand The Patient Voice SusieGear Speaker United Kingdom Q&A Main Hall
11 a.m. 12 p.m.	ISN-JSDT Joint Session TadashiTomo Moderator Japan Dialysis Membranes and Patient Survival AbeMasanori Speaker Japan Sex-specific Outcomes and Prognosis in Dialysis Care SaoriNishio Speaker Japan Practical Aspects of Preserving the Peritoneal Dialysis Membrane Ana Elizabeth Figueiredo Speaker Brazil 301 - 302			Climate and Conflict: Protecting Kidney Health Amid Global Disruptors AnukulGhimire Moderator Canada IkechiOkpechi Moderator Canada Mohamed Salah Moderator Egypt Heat, Sweat, and Silence: Two Decades of Uncovering Mesoamerican Nephropathy RamonGarcia Trabanino Speaker rgtrab@gmail.comEl Salvador When Funding Fades: Geopolitical Shifts and Kidney Health in Fragile Settings GraceKansiime Speaker Uganda Green Nephrology: Rethinking Sustainability in Dialysis Systems Winston Wing ShingFung Speaker Hong Kong, China Q&A 303			Cutting Edge Science in Diabetic Kidney Disease AhadQayyum Moderator Pakistan Complement Activation in Diabetic Kidney Disease MinChen Speaker China Applying Spatial Transcriptomics to Diabetic Kidney Disease Research BernhardDumoulin Speaker United States Applying Metabolomics to Understand Diabetic Kidney Disease ReikoInagi Speaker Japan Q&A 304			ISN-JSN-APSN Joint Session: Delivering Kidney Care in Humanitarian Crises KeiFukami Moderator Japan LilyMushahar Moderator Malaysia SerhanTuglular Moderator Turkey The ISN Role in Humanitarian Kidney Care AliAbu-Alfa Speaker abualfa@aub.edu.lbLebanon Disaster Preparedness in Kidney Care: Pitfalls and Solutions SerhanTuglular Speaker Turkey Earthquake Disaster: Lessons Learnt from Japan KeiFukami Speaker Japan Resilient Kidney Care: Adaptation and Recovery After a Disaster SabineKaram Speaker United States Q&A Main Hall
12:10 p.m. 1:10 p.m.	Plenary Lecture 4: Hugh de Wardener Lecture - Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy (Dennis Lo, Hong Kong, China) MegJardine Moderator Australia ShuchiAnand Moderator sanand3@health.ucdavis.eduUnited States Yogeshni Chandra YN Host Fiji Yuk Ming DennisLO Speaker Hong Kong, China Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy Yuk Ming DennisLO Speaker Hong Kong, China Congress Closing Main Hall